Fundraising Growth The Foundation has a large annual revenue (500M to 1B) and a broad donor network across the US, indicating substantial capacity for partnerships, sponsorships, and program funding opportunities through corporate gifts, cause-marketing campaigns, and major gifts.

Strategic Partnerships Active collaboration with biotech and pharma research partners (example: Antiverse) shows openness to co-development, antibody research, and external research collaborations that could align with your company’s therapeutic portfolio or R&D services.

Innovation Funding Significant investments into novel treatments and platforms (phage therapy and CFTR-targeted research) suggest opportunities to offer technology platforms, clinical data analytics, patient registry integration, or grant-writing support to accelerate early-stage research.

Five Year Plan The rollout of a Five-Year Strategic Plan indicates a stable, long-term funding and partnership horizon, ideal for multi-year sponsorships, named grants, and sustained corporate social responsibility (CSR) initiatives.

Global Reach With offices in over 60 locations and a worldwide recognition as a CF leader, there is potential for international collaborations, regional fundraising campaigns, and localization of educational or awareness programs to expand impact and donor engagement.